Latest Insider Transactions at Vir Biotechnology, Inc. (VIR)
This section provides a real-time view of insider transactions for Vir Biotechnology, Inc. (VIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vir Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vir Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,397
-7.16%
|
$43,970
$10.11 P/Share
|
|
Nov 05
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,347
-3.68%
|
$21,123
$9.47 P/Share
|
|
Nov 01
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,403
-2.15%
|
$9,821
$7.2 P/Share
|
|
Oct 23
2024
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Indirect |
1,196,540
-34.19%
|
-
|
|
Oct 23
2024
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Indirect |
598,270
+50.0%
|
-
|
|
Oct 23
2024
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Direct |
598,270
+45.41%
|
-
|
|
Sep 09
2024
|
Janet Napolitano Director |
SELL
Open market or private sale
|
Direct |
12,190
-51.21%
|
$85,330
$7.8 P/Share
|
|
Jul 15
2024
|
Mark Eisner EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Jun 12
2024
|
Marianne De Backer Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
53,118
+50.0%
|
-
|
|
Jun 12
2024
|
Marianne De Backer Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
53,118
-7.83%
|
-
|
|
Jun 11
2024
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
4,000
-21.48%
|
$40,000
$10.95 P/Share
|
|
May 30
2024
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+30.05%
|
-
|
|
May 30
2024
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+0.6%
|
-
|
|
May 30
2024
|
George A Scangos Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+6.2%
|
-
|
|
May 30
2024
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.15%
|
-
|
|
May 30
2024
|
Robert Nelsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+1.35%
|
-
|
|
May 30
2024
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.15%
|
-
|
|
May 30
2024
|
Robert J More Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+14.63%
|
-
|
|
May 30
2024
|
Jeffrey S. Hatfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.15%
|
-
|
|
May 29
2024
|
Norbert W Bischofberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
-
|
|
May 29
2024
|
Ramy Farid Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
-
|
|
Apr 03
2024
|
Marianne De Backer Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
72,995
-9.71%
|
$656,955
$9.46 P/Share
|
|
Apr 01
2024
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,711
-2.01%
|
$27,110
$10.05 P/Share
|
|
Mar 27
2024
|
Sung Lee EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,008
-5.64%
|
$54,072
$9.89 P/Share
|
|
Feb 26
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
17,722
-13.56%
|
$194,942
$11.65 P/Share
|
|
Feb 22
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,028
-7.13%
|
$100,280
$10.05 P/Share
|
|
Feb 22
2024
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,568
-5.5%
|
$145,680
$10.05 P/Share
|
|
Feb 22
2024
|
Sung Lee EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+27.3%
|
-
|
|
Feb 22
2024
|
Marianne De Backer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+18.89%
|
-
|
|
Feb 22
2024
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
12,296
-8.36%
|
$122,960
$10.05 P/Share
|
|
Feb 22
2024
|
Ann M. Hanly EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+18.1%
|
-
|
|
Feb 20
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
16,872
-10.7%
|
$168,720
$10.22 P/Share
|
|
Feb 16
2024
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,878
-6.46%
|
$108,780
$10.24 P/Share
|
|
Feb 16
2024
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,321
-1.24%
|
$33,210
$10.24 P/Share
|
|
Jan 02
2024
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+9.74%
|
$80,000
$1.32 P/Share
|
|
Oct 19
2023
|
Robert J More Director |
BUY
Other acquisition or disposition
|
Indirect |
6,405
+1.28%
|
-
|
|
Oct 19
2023
|
Robert J More Director |
SELL
Other acquisition or disposition
|
Direct |
6,405
-14.21%
|
-
|
|
Oct 17
2023
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Indirect |
3,500,000
+50.0%
|
-
|
|
Oct 17
2023
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Indirect |
1,750,000
-100.0%
|
-
|
|
Oct 17
2023
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Direct |
1,750,000
-91.22%
|
-
|
|
Sep 15
2023
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Indirect |
5,377,590
-99.81%
|
-
|
|
Sep 15
2023
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Indirect |
1,750,000
+50.0%
|
-
|
|
Sep 15
2023
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Direct |
1,750,000
+47.7%
|
-
|
|
Jun 30
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
700
-0.0%
|
$17,500
$25.11 P/Share
|
|
Jun 30
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
18,000
-1.35%
|
$432,000
$24.66 P/Share
|
|
Jun 29
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
89,942
-0.54%
|
$2,248,550
$25.18 P/Share
|
|
Jun 28
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,010
-0.04%
|
$175,250
$25.1 P/Share
|
|
Jun 20
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,902
-0.06%
|
$247,550
$25.18 P/Share
|
|
Jun 16
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
128,144
-0.38%
|
$3,203,600
$25.73 P/Share
|
|
Jun 15
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
55,182
-0.16%
|
$1,379,550
$25.94 P/Share
|